Case Study

Digging through boxes, waiting for couriers, finding smashed VHS tapes in the mail, jockeying back and forth between multiple modalities. Like at other hospitals across the country, the manual, tape- and film-based workflow in the pediatric cardiology department at Mercy Children’s Hospital in Toledo, Ohio, had stagnated. The workflow had quadrupled in the time it took the cardiologists to read echocardiograms for the hospital and four outreach centers, resulting in a report turnaround time that could be as long as five to seven days.

Home October 07, 2011
Home
News

October 7, 2011 — There is good news for cancer patients whose medical treatments put them at risk for future cardiac problems: using strain echocardiography can help physicians detect early signs of cardiac toxicity. To get this information out, the American Society of Echocardiography (ASE) is preparing a guideline document outlining the best way to evaluate cancer patients. ASE has also funded a research study to enhance identification of patients who are at risk.

Home October 07, 2011
Home
News

October 7, 2011 – ValveXchange Inc., has performed successful first-in-man (FIM) surgeries demonstrating the practicality and advantages of its novel Vitality two-part heart valve system. Two renowned United States cardiac surgeons, Lars Svensson, M.D., Ph.D., of The Cleveland Clinic and W. Randolph Chitwood, M.D. of The East Carolina Heart Institute, performed the surgeries; they were working with Adrian Ebner, M.D. at his facilities in Asuncion, Paraguay.

Home October 07, 2011
Home
News

October 7, 2011 — Among individuals 65 years and older, as many as 30 percent have aortic valve sclerosis or stenosis and, as a result of their deteriorating health, cannot enjoy a normal lifestyle.

Home October 07, 2011
Home
News

October 7, 2011 — U.S. Food and Drug Administration (FDA) Commissioner Margaret A. Hamburg, M.D., released a blueprint containing immediate steps to drive biomedical innovation, while improving the health of Americans.

Home October 07, 2011
Home
News

October 7, 2011 — Boston Scientific Corp. has started patient enrollment in the Omega clinical trial, designed to evaluate the company's Omega platinum chromium bare-metal coronary stent system. The trial will test the safety and effectiveness of OMEGA in treating patients with a single coronary artery lesion.

Home October 07, 2011
Home
News

October 7, 2011 — Biosensors has announced completion of its acquisition of JW Medical Systems Ltd. (JWMS), one of the top three suppliers of drug-eluting stents (DES) in China.

Home October 07, 2011
Home
Feature | Helen Kuhl

Although computerized physician order entry (CPOE) systems have been around for a few years, only a few vendors really embraced the market with robust offerings and only a few healthcare providers showed interest in adopting them — until the 2009 passage of the American Reinvestment and Recovery Act (ARRA). After that, the landscape changed considerably, as many providers wanted to take advantage of reimbursements available in meeting meaningful use (MU) requirements and the rate of adoption grew significantly.

Home October 06, 2011
Home
News

October 6, 2011 – Cambridge Heart Inc. announced it has concluded data review for the company’s microvolt T-wave alternans-computer-aided detection (MTWA-CAD) feasibility study. The data suggest MTWA is a statistically significant predictor of ischemic events. In addition, the data revealed instances where the company's MTWA test identified underlying coronary artery disease that was not identified by other standard diagnostic modalities.

Home October 06, 2011
Home
Technology

During RSNA 2011, Infinitt will showcase its latest advances in image and information management across the enterprise.

Home October 05, 2011
Home
Feature

Abbott began enrolling U.S. patients in the EXCEL trial, which will compare the use of the Xience Prime or Xience V drug-eluting strents to coronary artery bypass graft (CABG) surgery for effectiveness of left main revascularization. The large-scale trial will attempt to show stenting has comparable or superior outcomes to CABG, which has long been the dream of interventional cardiology.

Home October 04, 2011
Home
News

October 4, 2011 – Roche announced plans today to expand its coagulation testing product line in North America beyond physician offices and outpatient clinics with the development of a full line of coagulation analyzers for hospital and reference laboratories. The new line is expected to be introduced in the United States and Canada in 2014, subject to regulatory approval and other requirements.

Home October 04, 2011
Home
News

October 4, 2011 – The International Contrast Ultrasound Society (ICUS) submitted a petition this week to the U.S. Food and Drug Administration (FDA) requesting removal of the boxed warnings on ultrasound contrast agents. The members of the group say this would bring the product labeling into line with the current body of scientific research, which it says clearly demonstrates the safety and clinical benefits of these imaging products.

Home October 04, 2011
Home
Technology

Toshiba America Medical Systems will showcase the Infinix VF-i bi-plane angiography system with dual 12”x12” mid-size ...

Home October 03, 2011
Home
News

October 3, 2011 – Maquet Cardiovascular has signed a definitive agreement to acquire Atrium Medical Corp. for $680 million. Atrium is a medical device technologies developer for interventional cardiology and radiology, chest trauma care and thoracic drainage, vascular surgery and general surgery. Atrium will operate as an independent, self-contained business unit of Maquet and will be led by current Atrium president Trevor Carlton.

Home October 03, 2011
Home
Subscribe Now